Promedica International and Synergy Research Group Announce Strategic Alliance for Expansion of Global Clinical Research Services
SynRG’s expertise and Eastern European location are cited by PMI
as key reasons for alliance.
Costa Mesa, California – August 2, 2007 – Promedica International (PMI), a USA-based Contract Research Organization (CRO) providing services to the medical device, biotech and pharmaceutical industries, announced today the establishment of a new strategic alliance with Synergy Research Group (SynRG), a Russian based CRO.
SynRG, which specializes in Phase II-IV clinical research, serves Russia and the Commonwealth of Independent States (CIS) markets through its corporate office in Moscow and four other offices throughout Russia. The company’s services include project management, study management and monitoring, clinical quality assurance, medical writing and regulatory support.
PMI chose to formalize the alliance with SynRG based on the firms’ cultural similarities in terms of client orientation and service. “The PMI-SynRG alliance expands both firms’ capabilities. Our combined experience and service provider relationships in clinical research facilitate comprehensive, efficient clinical project plans and implementation in North America, Russia and CIS countries. Over the years we have reviewed various alliance opportunities – we find SynRG’s capabilities and culture to be a good match with PMI’s focus on people, processes and performance”, said Ellen Palo, PMI founder.
“The PMI-Synergy alliance creates an excellent value for our clients”, stated Elena Zhuk, founder of SynRG. “Now our clients will have the opportunity to perform study activities in North America, Russian and CIS member states using common project and data management resources and a single set of standard operating procedures.”
Shannon Stoddard, Director of Clinical Services at PMI, will oversee the integration of the firms’ standard operating procedures (SOP) and systems to streamline project implementation activities. Ms. Stoddard said, “It is very positive to have this alliance. SynRG’s specialized knowledge in clinical research enables us to confidently provide our clients with thoughtful study planning processes, suggestions for proven Russian study sites, and in-country monitoring and site management.”
About Promedica International
Promedica International (PMI) is a privately held corporation with headquarters located in Costa Mesa, California. Founded in 1985, the company provides clinical research services to the medical device, biotech and pharmaceutical industries. ISO 9001:2000 certified and servicing a range of medical specialties and therapeutic areas, the company has extensive experience in clinical study service projects, and has provided support for studies evaluating a variety of medical specialty treatments.
For more information, please visit www.promedica-intl.com.
Synergy Research Group (SynRG™) is a Russian contract research organization, which has been successfully operating throughout Russia and the CIS member-states since 2002. SynRG™ offers a broad range of services for conducting clinical trials for Russian and foreign pharmaceutical and biotechnological companies – from regulatory affairs to pharmaco-economic surveys. The company has its own clinical depot in Moscow. Today, SynRG is represented in Moscow, Saint-Petersburg, Novosibirsk, Yekaterinburg and Almaty. The company’s headquarters are in Moscow.
For more information, please visit www.synrg-pharm.com.